Controlling Reaction Routes in Noble-Metal-Catalyzed Conversion of Aryl Ethers.

Julian Schmid, Meng Wang, Oliver Y Gutiérrez, R Morris Bullock, Donald M Camaioni, Johannes A Lercher

Open access · hybridAbstract read

In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.8field-weighted citation impact, top 35% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 12 citations in OpenAlex.

Controlling Reaction Routes in Noble-Metal-Catalyzed Conversion of Aryl Ethers.Angewandte Chemie (International ed. in English) · 2022
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Julian SchmidInstitute for Integrated Catalysis, Pacific Northwest National Laboratory (PNNL), P.O. Box 999, Richland, WA 99352, USA.

Meng WangInstitute for Integrated Catalysis, Pacific Northwest National Laboratory (PNNL), P.O. Box 999, Richland, WA 99352, USA.

Oliver Y GutiérrezInstitute for Integrated Catalysis, Pacific Northwest National Laboratory (PNNL), P.O. Box 999, Richland, WA 99352, USA.ORCID http://orcid.org/0000-0001-9163-4786

R Morris BullockInstitute for Integrated Catalysis, Pacific Northwest National Laboratory (PNNL), P.O. Box 999, Richland, WA 99352, USA.

Donald M CamaioniInstitute for Integrated Catalysis, Pacific Northwest National Laboratory (PNNL), P.O. Box 999, Richland, WA 99352, USA.

Johannes A LercherInstitute for Integrated Catalysis, Pacific Northwest National Laboratory (PNNL), P.O. Box 999, Richland, WA 99352, USA.ORCID http://orcid.org/0000-0002-2495-1404

Pacific Northwest National Laboratory · US

Funding

Basic Energy Sciences 47319

6 · The paper itself

Abstract

Hydrogenolysis and hydrolysis of aryl ethers in the liquid phase are important reactions for accessing functionalized cyclic compounds from renewable feedstocks. On supported noble metals, hydrogenolysis is initiated by a hydrogen addition to the aromatic ring followed by C-O bond cleavage. In water, hydrolysis and hydrogenolysis proceed by partial hydrogenation of the aromatic ring prior to water or hydrogen insertion. The mechanisms are common for the studied metals, but the selectivity to hydrogenolysis increases in the order Pd<Rh<Ir<Ru≈Pt in decalin and water; the inverse was observed for the selectivity to hydrolysis in water. Hydrogenolysis selectivity correlates with the Gibbs free energy of hydrogen adsorption. Hydrogenolysis has the highest standard free energy of activation and a weak dependence on H

Indexed as

Biomass ConversionC−O Bond CleavageHydrogenNoble-Metal CatalystsSolvent Effects

Identifiers

PMID35482977

DOI10.1002/anie.202203172

PMCPMC9400965

OpenAlexW4226278357

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.